title: [Testing for immunogenic and protective properties of vaccine against tissue-inactivated rabies].
abstract: The immunogenic and protective potency was tested of vaccine against inactivated tissue rabies developed from the Vnukovo-32 strain, and produced in the Bioveta state corporation at Ivanovice in Haná. In 21 days after an i. m. application of 3 cm3 of vaccine, the average titre of virus-neutralizing antibodies was found to be 1:47. In this period the animals were revaccinated in the same way. The average titre of virus-neutralizing antibodies was 1:99 three months after revaccination, 1:57 in six months and 1:24 in nine months. In this period a challenge test was performed in a dog using the dose of 10(5) MICLD50 of street rabies virus. This dose was implanted i. m. into masticatory muscles. Another dog was infected experimentally 18 months after immunization. The experiment has proved the good immunogenic potency of vaccine against inactivated tissue rabies and its ability to induce the protection of vaccinated dogs from the strees infection with street rabies virus. The control rabies vaccine of foreign make RABISIN was tested in a similar way.
authors.affiliation: Bioveta, s. p., Ivanovice na Hané.
authors.forename: V
authors.initials: V
authors.lastname: Vrzal
authors.forename: Z
authors.initials: Z
authors.lastname: Cupera
authors.forename: J
authors.initials: J
authors.lastname: Chumela
authors.forename: L
authors.initials: L
authors.lastname: Zatloukal
mesh_terms: D000818:Animals; D000914:Antibodies, Viral / Q000032:analysis; D004283:Dog Diseases / Q000276:immunology / Q000517:prevention & control*; D004285:Dogs; D009500:Neutralization Tests; D011818:Rabies / Q000276:immunology / Q000517:prevention & control*; D011819:Rabies Vaccines / Q000276:immunology*; D011820:Rabies virus / Q000276:immunology; D015164:Vaccines, Inactivated / Q000276:immunology
chemical_list: D000914:Antibodies, Viral; D011819:Rabies Vaccines; D015164:Vaccines, Inactivated
vernacular_title: Ovĕrování imunogenních a protekcních schopností vakcíny proti vzteklinĕ tkánové inaktivované.